Hagop M. Kantarjian, MD – Ponatinib, Blinatumomab, and CD19 Acute Lymphoblastic Leukemia 1 Min Read10 Hagop M. Kantarjian, MD. Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,…
MRD: 2023 ASH ALL Inotuzumab Update [Slides] – Van Huynh, MD MOASC Acute Lymphoblastic Leukemia 8 Mins Read14 MRD: Inotuzumab, GMALL, Ponatinib & Blinatumomab ASH Updates in Acute Lymphoblastic Leukemia/Immunotherapy By Van Huynh, MD Today I spoke at…
2023 ASH ALL Inotuzumab Update [Slides] – Van Huynh, MD MOASC Acute Lymphoblastic Leukemia 19 Mins Read6 Inotuzumab, GMALL, Ponatinib & Blinatumomab ASH Updates in Acute Lymphoblastic Leukemia By Van Huynh, MD Updates in acute lymphoblastic leukemia…
